Tirzepatide is a single-molecule dual agonist of the GIP and GLP-1 receptors.
Mechanism of Action:
Engages both incretin receptors, with a fatty-acid side chain that extends circulating half-life through albumin binding.
Research Applications:
- Dual incretin-receptor pharmacology
- cAMP signaling studies
- Comparison with single- and triple-agonist compounds
For laboratory research use only. Not for human or animal consumption.
Tirzepatide at a glance
| Compound type | Single-molecule dual incretin agonist |
|---|---|
| Primary research target | GIP and GLP-1 receptors |
| Documentation | Batch-specific Certificate of Analysis (see the COA tab) |
| Supplied for | Laboratory research use only |
Frequently asked questions
What is Tirzepatide?
Tirzepatide is a single-molecule dual agonist of the GIP and GLP-1 receptors.
What do researchers study Tirzepatide for?
Engages both incretin receptors, with a fatty-acid side chain that extends circulating half-life through albumin binding.
Where can I find the Certificate of Analysis?
In the COA tab on this page. Reports come from independent third-party laboratories, are tied to a specific batch, and carry a verification key that can be checked on the testing lab’s website.
Is Tirzepatide for human use?
No. Karma Research Peptides supplies Tirzepatide strictly for in-vitro laboratory research. It is not for human or animal consumption, and we do not provide dosing or human-use guidance.
